310 related articles for article (PubMed ID: 28860837)
1. The role of novel biomarkers in predicting diabetic nephropathy: a review.
Uwaezuoke SN
Int J Nephrol Renovasc Dis; 2017; 10():221-231. PubMed ID: 28860837
[TBL] [Abstract][Full Text] [Related]
2. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
[TBL] [Abstract][Full Text] [Related]
3. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
4. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
Thipsawat S
Diab Vasc Dis Res; 2021; 18(6):14791641211058856. PubMed ID: 34791910
[TBL] [Abstract][Full Text] [Related]
5. Urinary biomarkers in diabetic nephropathy.
Soltani-Fard E; Taghvimi S; Karimi F; Vahedi F; Khatami SH; Behrooj H; Deylami Hayati M; Movahedpour A; Ghasemi H
Clin Chim Acta; 2024 Jun; 561():119762. PubMed ID: 38844018
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
7. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
Quan KY; Yap CG; Jahan NK; Pillai N
Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
[TBL] [Abstract][Full Text] [Related]
8. Diabetic Nephropathy - possibilities of early laboratory diagnostics and course prediction (review of literature).
Popykhova EB; Ivanov AN; Stepanova TV; Lagutina DD; Savkina AA
Klin Lab Diagn; 2021 Oct; 66(10):593-602. PubMed ID: 34665945
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Management of Diabetic Nephropathy in Western Countries.
Satirapoj B; Adler SG
Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
[TBL] [Abstract][Full Text] [Related]
10. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
[TBL] [Abstract][Full Text] [Related]
11. Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
Mu X; Yang M; Ling P; Wu A; Zhou H; Jiang J
Diabetes Metab Syndr Obes; 2022; 15():247-256. PubMed ID: 35125878
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.
Campion CG; Sanchez-Ferras O; Batchu SN
Can J Kidney Health Dis; 2017; 4():2054358117705371. PubMed ID: 28616250
[TBL] [Abstract][Full Text] [Related]
13. Diabetic nephropathy: Is it time yet for routine kidney biopsy?
Gonzalez Suarez ML; Thomas DB; Barisoni L; Fornoni A
World J Diabetes; 2013 Dec; 4(6):245-55. PubMed ID: 24379914
[TBL] [Abstract][Full Text] [Related]
14. Insights into predicting diabetic nephropathy using urinary biomarkers.
Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
16. Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients.
Fiseha T
Biomark Res; 2015; 3():16. PubMed ID: 26146561
[TBL] [Abstract][Full Text] [Related]
17. The Wnt Signaling Pathway in Diabetic Nephropathy.
Wang H; Zhang R; Wu X; Chen Y; Ji W; Wang J; Zhang Y; Xia Y; Tang Y; Yuan J
Front Cell Dev Biol; 2021; 9():701547. PubMed ID: 35059392
[TBL] [Abstract][Full Text] [Related]
18. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of Early Markers of Diabetic Nephropathy by Linagliptin in Fructose-Streptozotocin-Induced Type 2 Diabetic Rats.
Oraby MA; El-Yamany MF; Safar MM; Assaf N; Ghoneim HA
Nephron; 2019; 141(4):273-286. PubMed ID: 30699409
[TBL] [Abstract][Full Text] [Related]
20. Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.
Fiseha T; Tamir Z
Int J Nephrol; 2016; 2016():4647685. PubMed ID: 27293888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
